Companies operating in the pharmaceutical and related sectors such as healthcare must grapple with cutting-edge scientific development as well as shifting regulatory regimes, which complicate corporate mergers and acquisitions, managing intellectual property portfolios and patents, and litigating disputes. The ethical dimension makes it imperative to have the right legal advice.
Curtis provides a wide range of legal services to clients in the pharmaceutical sector. Our pharmaceutical attorneys advise manufacturers, funds and institutions on transactions and disputes involving branded and generic pharmaceuticals, biotechnology equipment, clinical systems, nanotechnology, medical software and prescription drugs, drug delivery and drug packaging.
We have advised on a diverse range of mergers and acquisitions and other transactions.
The wider Curtis team includes experts in the field of healthcare compliance, as well as former medical doctors and lawyers with experience in pharmaceutical patent and regulatory (Hatch-Waxman) litigation in the U.S.
This has enabled Curtis to develop a range of experience in the pharmaceutical sector, ranging from healthcare issues to compliance and specialist intellectual property. Our healthcare attorneys have also advised on the development and financing of healthcare infrastructure projects such as hospitals in many countries, by way of PPI as well as traditional project finance and Islamic finance.
Eric Stenshoel
Counsel
Commercial Disputes - Litigation
Corporate
Tax
Legal 500 USA, 2019
Legal 500: USA M&A(Middle-Market) 2017
Legal 500 USA 2019